文献速递心脑血管急症

血流储备分数治疗阈值的依从性与主要不良心脏事件的关联

Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.
PubMed 文献 · JAMA · 2020-01-01
一句话结论在单支血管FFR评估的冠心病患者中,按循证FFR阈值(≤0.80缺血)行PCI与5年MACE降低相关,而>0.80非缺血病变行PCI与MACE升高相关。

该回顾性、多中心、基于人群的队列研究纳入2013年4月1日至2018年3月31日加拿大安大略省接受单支血管FFR评估的成人冠心病患者(排除ST段抬高型心肌梗死),随访至2019年3月31日,共9106例。按FFR≤0.80(缺血)和>0.80(非缺血)分两个队列,比较PCI与未PCI的5年主要不良心脏事件(MACE:死亡、心肌梗死、不稳定型心绞痛或紧急血运重建)。缺血FFR队列中,PCI与较低MACE发生率相关(31.5% vs 39.1%;HR 0.77,95%CI 0.63-0.94);非缺血FFR队列中,PCI与较高MACE发生率相关(33.3% vs 24.4%;HR 1.37,95%CI 1.14-1.65)。结论支持依据循证FFR阈值施行PCI。

要点

  • 缺血FFR(≤0.80)患者行PCI较未行PCI的5年MACE发生率更低:31.5% vs 39.1%,HR 0.77(95%CI 0.63-0.94)。
  • 非缺血FFR(>0.80)患者行PCI较未行PCI的5年MACE发生率更高:33.3% vs 24.4%,HR 1.37(95%CI 1.14-1.65)。
  • 缺血FFR队列中75.3%接受PCI、24.7%仅药物治疗;非缺血FFR队列中12.6%接受PCI、87.4%仅药物治疗。
  • 研究为回顾性、多中心、基于人群的队列,采用逆概率治疗加权校正治疗选择偏倚。
  • 在单支血管FFR评估的冠心病患者(排除STEMI)中,按循证FFR阈值决策PCI与更好的5年结局相关。

适用人群与场景

  • 接受单支血管FFR评估的成人冠心病患者,来自加拿大安大略省2013年4月1日至2018年3月31日,随访至2019年3月31日。
  • 排除ST段抬高型心肌梗死患者。
  • 两个队列:FFR≤0.80为缺血队列(2693例),FFR>0.80为非缺血队列(6413例)。

诊断标准与关键阈值

  • FFR≤0.80定义为缺血;FFR>0.80定义为非缺血。

处置流程与药物剂量

  • 在缺血FFR(≤0.80)队列中,75.3%接受PCI,24.7%仅药物治疗;PCI与5年MACE较低相关(31.5% vs 39.1%;HR 0.77,95%CI 0.63-0.94)。
  • 在非缺血FFR(>0.80)队列中,12.6%接受PCI,87.4%仅药物治疗;PCI与5年MACE较高相关(33.3% vs 24.4%;HR 1.37,95%CI 1.14-1.65)。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:回顾性、多中心、基于人群的队列研究;样本量9106例(平均年龄65岁,SD 10.6;女性35.3%);无中心数信息。
  • 干预与对照:PCI vs 未行PCI;采用逆概率治疗加权校正治疗选择偏倚。
  • 主要终点:5年MACE(死亡、心肌梗死、不稳定型心绞痛或紧急血运重建)。
  • 缺血FFR队列:PCI组MACE 31.5% vs 未PCI组39.1%;HR 0.77(95%CI 0.63-0.94)。
  • 非缺血FFR队列:PCI组MACE 33.3% vs 未PCI组24.4%;HR 1.37(95%CI 1.14-1.65)。
  • 关键次要终点及不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:回顾性、多中心、基于人群的队列研究。
  • 证据等级或推荐强度:原文未提及。
  • 局限:回顾性设计;观察性研究,即使采用逆概率治疗加权仍可能存在残余混杂;单支血管FFR评估人群,外推需谨慎;排除STEMI。

对床旁实践的改变

  • 在单支血管FFR评估的冠心病患者(排除STEMI)中,FFR≤0.80的缺血病变行PCI与5年MACE降低相关,支持按循证FFR阈值施行PCI。
  • FFR>0.80的非缺血病变行PCI与5年MACE升高相关,提示应避免在此类病变中常规行PCI。
  • 该研究为回顾性队列,不能确立因果关系;临床决策仍需结合患者具体情况。
  • 不适用于ST段抬高型心肌梗死患者,也不适用于多支血管FFR评估人群(原文未纳入)。

指南或共识出处

  • 原文未提及指南或共识名称;研究发表于JAMA。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

IMPORTANCE: Fractional flow reserve (FFR) is an invasive measurement used to assess the potential of a coronary stenosis to induce myocardial ischemia and guide decisions for percutaneous coronary intervention (PCI). It is not known whether established FFR thresholds for PCI are adhered to in routine interventional practice and whether adherence to these thresholds is associated with better clinical outcomes.

OBJECTIVE: To assess the adherence to evidence-based FFR thresholds for PCI and its association with clinical outcomes.

DESIGN, SETTING, AND PARTICIPANTS: A retrospective, multicenter, population-based cohort study of adults with coronary artery disease undergoing single-vessel FFR assessment (excluding ST-segment elevation myocardial infarction) from April 1, 2013, to March 31, 2018, in Ontario, Canada, and followed up until March 31, 2019, was conducted. Two separate cohorts were created based on FFR thresholds (≤0.80 as ischemic and >0.80 as nonischemic). Inverse probability of treatment weighting was used to account for treatment selection bias.

EXPOSURES: PCI vs no PCI.

MAIN OUTCOMES AND MEASURES: The primary outcome was major adverse cardiac events (MACE) defined by death, myocardial infarction, unstable angina, or urgent coronary revascularization.

RESULTS: There were 9106 patients (mean [SD] age, 65 [10.6] years; 35.3% female) who underwent single-vessel FFR measurement. Among 2693 patients with an ischemic FFR, 75.3% received PCI and 24.7% were treated only with medical therapy. In the ischemic FFR cohort, PCI was associated with a significantly lower rate and hazard of MACE at 5 years compared with no PCI (31.5% vs 39.1%; hazard ratio, 0.77 [95% CI, 0.63-0.94]). Among 6413 patients with a nonischemic FFR, 12.6% received PCI and 87.4% were treated with medical therapy only. PCI was associated with a significantly higher rate and hazard of MACE at 5 years compared with no PCI (33.3% vs 24.4%; HR, 1.37 [95% CI, 1.14-1.65]) in this cohort.

CONCLUSIONS AND RELEVANCE: Among patients with coronary artery disease who underwent single-vessel FFR measurement in routine clinical practice, performing PCI, compared with not performing PCI, was significantly associated with a lower rate of MACE for ischemic lesions and a higher rate of MACE for nonischemic lesions. These findings support the performance of PCI procedures according to evidence-based FFR thresholds.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Sud M, Han L, Koh M, et al. Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease. JAMA. 2020. PMID: 33185655. doi:10.1001/jama.2020.22708

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。